Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

4 days ago 2

ARTICLE AD BOX

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultation company less than two months after it started.

Read Entire Article

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

ARTICLE AD BOX

Related

Three Police Officers Caught On Video Brutalising Naked Tric...

I’ve been a stay-at-home mom for 10 years. Do I take a part-...

I was married twice. Can I switch from my Social Security be...

RIGHT SIDEBAR TOP AD

Trending

Popular

Gene Hackman’s Wife Died at Least a Day Later Than Originall...

A Dialogue Session Discusses The Central Bank's Measures For...

CPF Savings In 2025. Top Up to MA.

CVC Capital Partners Half Year 2024 Report Analysis

Nvidia GTC 2025: What to expect from Nvidia's biggest event ...

RIGHT SIDEBAR BOTTOM AD